This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Nootropics and compounds researched for cognitive enhancement.
Also known as: PNB-0408
Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. It is considered one of the most potent cognitive enhancers ever tested in animal models — reportedly 7 orders of magnitude more potent than BDNF at improving cognitive performance in rodent Alzheimer's models. Exclusively used by the research and biohacking community with no human clinical trial data available.
Also known as: ACTH 4-10
A synthetic nootropic and neuroprotective peptide derived from ACTH, studied for cognitive enhancement, stroke recovery, and focus.
Also known as: TP-7
A synthetic anxiolytic and nootropic peptide derived from tuftsin, studied for anxiety, cognitive enhancement, and immune modulation.
NSI-189 is a novel synthetic compound developed by Neuralstem Inc. that stimulates neurogenesis in the human hippocampus. Phase 2 trials for major depressive disorder showed improvements in subjective cognitive function, depression scores, and positive affect despite not reaching primary endpoints. It has a dedicated following in the biohacking community for its reported hippocampal neurogenesis, emotional blunting reversal, and unique cognitive profile unlike any other nootropic.
Protocols, price drops, and new compounds for focus & cognition.
No spam. Unsubscribe anytime.